AROMICS is a biotech company committed to the discovery and development of novel drugs and diagnostic methods to target relevant human diseases and improve patient’s quality of life.

We believe that OMIC technologies represent an important first step towards gaining biological insights into:

  • How drugs work, giving them added value, reducing attrition rates and advancing  through the clinic.
  • Determining clinically predictive molecular endpoints that help physicians manage the disease, drive prescriptions and monitor drug response.


11/23/2022 | The value of intangibles: Industrial and intellectual property, a strategic element of the company
Next 23/11/2022 will take place, at the College of Economists of Catalonia,... More

09/28/2022 | European research and innovation days
European Research and Innovation Days is the European Commission’s annual... More


11/26/2022 | Convention against asbestos and its consequences
The collective of Macosa-Alstom Retirees Affected by Asbestos, together with... More

01/20/2022 | AROMICS - one of the winners of Chemostart V Edition Program
ChemoStart is a global programme which provides support for startups and companies designing... More